Fully human bispecific anti-CD20/anti-CD19 CAR T cells

· Medical College of Wisconsin

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Fully human bispecific anti-CD20/anti-CD19 CAR T cells, covering 2026-01-13 to 2026-01-13. Get the full timeline:

Most recent: Clinical Trial Update: Fully Human Bispecific Anti-CD20, Anti-CD19 CAR T Cells for Patients With Relapsed and/or Refractory B Cell Malignancies [Phase 1]

See pricing